DAVIS BLAINE (Chief Financial Officer) received a stock award from CARTESIAN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2026ACC: 0001453687-26-000033
Officer· Chief Financial Officer
Since Nov 2022
+146K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
146K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+37K
Price / share
—
Trade value
—
% of position
39.0%
1/2/2026
94.81K→131.81K
Total
Net shares
+37K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +37K | — | — | 39.0% | 94.81K | 131.81K |
| Total | +37K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
109K shares
Shares
+109K
Strike price
6.76
Held after
109K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock109K shares | 1/2/2026 | A · Award | +109K | 6.76 | — | 109K |